Adverse events5,995

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 5,995

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	1st Line of Therapy	4	1,849
other	Anaemia	Blood and lymphatic system disorders	2nd Line of Therapy	2	773
other	Anaemia	Blood and lymphatic system disorders	3rd Line of Therapy	5	455
other	Anaemia	Blood and lymphatic system disorders	4th Line of Therapy	2	239
other	Anaemia	Blood and lymphatic system disorders	>4th Line of Therapy	3	181
other	Anaemia	Blood and lymphatic system disorders	Robustness Concerns: 1st Line of Therapy	0	0
other	Anaemia	Blood and lymphatic system disorders	Robustness Concerns: 2nd Line of Therapy	0	0
other	Anaemia	Blood and lymphatic system disorders	Robustness Concerns: 3rd Line of Therapy	0	0
other	Anaemia	Blood and lymphatic system disorders	Robustness Concerns: 4th Line of Therapy	0	0
other	Anaemia	Blood and lymphatic system disorders	Robustness Concerns: >4th Line of Therapy	0	0
other	Anaemia	Blood and lymphatic system disorders	Robustness Concerns: Unknown Line of Therapy	0	0
other	Anaemia of malignant disease	Blood and lymphatic system disorders	1st Line of Therapy	0	1,849
other	Anaemia of malignant disease	Blood and lymphatic system disorders	2nd Line of Therapy	0	773
other	Anaemia of malignant disease	Blood and lymphatic system disorders	3rd Line of Therapy	0	455
other	Anaemia of malignant disease	Blood and lymphatic system disorders	4th Line of Therapy	0	239
other	Anaemia of malignant disease	Blood and lymphatic system disorders	>4th Line of Therapy	1	181
other	Anaemia of malignant disease	Blood and lymphatic system disorders	Robustness Concerns: 1st Line of Therapy	0	0
other	Anaemia of malignant disease	Blood and lymphatic system disorders	Robustness Concerns: 2nd Line of Therapy	0	0
other	Anaemia of malignant disease	Blood and lymphatic system disorders	Robustness Concerns: 3rd Line of Therapy	0	0
other	Anaemia of malignant disease	Blood and lymphatic system disorders	Robustness Concerns: 4th Line of Therapy	0	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02761187/events

API reference For AI assistants

Adverse events5,995

Sources 3

Read this list from software.